Literature DB >> 11964750

Factors controlling smooth muscle proliferation and airway remodelling.

Judith L Black1, Peter R A Johnson.   

Abstract

It is clear that airway smooth muscle plays an important role in the hyperresponsiveness and remodelling that occur in the asthmatic airway. This is by virtue of its roles as a contractile cell, a cell that undergoes proliferation as part of the inflammatory response, a cell that actively participates in the inflammatory response via the production of cytokines and chemokines, and perhaps as a cell that undergoes migration. Now that airway smooth muscle cells cultured from asthmatic patients have been studied in vitro, it is apparent that there is an abnormality in the growth of these cells such that they grow more rapidly than cells derived from nonasthmatic patients. This raises the possibility of identifying the exact point(s) in the signal transduction pathways at which this abnormality occurs. To do this it is necessary to define precisely the mitogenic pathways that lead to proliferation in the airway smooth muscle cell, and this information is accumulating rapidly. The possibility is raised for new therapeutic targets that are aimed specifically at the airway smooth muscle, leading to an effective method for reversing or preventing the airway remodelling that accompanies chronic severe asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964750     DOI: 10.1097/00130832-200202000-00008

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  5 in total

1.  Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.

Authors:  Shinsuke Yasuda; Nasa Morokawa; G William Wong; Andrea Rossi; Mallur S Madhusudhan; Andrej Sali; Yuko S Askew; Roberto Adachi; Gary A Silverman; Steven A Krilis; Richard L Stevens
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

2.  A common cortactin gene variation confers differential susceptibility to severe asthma.

Authors:  Shwu-Fan Ma; Carlos Flores; Michael S Wade; Steven M Dudek; Dan L Nicolae; Carole Ober; Joe G N Garcia
Journal:  Genet Epidemiol       Date:  2008-12       Impact factor: 2.135

Review 3.  The role of ADAM33 in the pathogenesis of asthma.

Authors:  Julie A Cakebread; H-M Haitchi; John W Holloway; Robert M Powell; Tim Keith; Donna E Davies; Stephen T Holgate
Journal:  Springer Semin Immunopathol       Date:  2003-11-15

4.  CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation.

Authors:  Saula Ravasi; Simona Citro; Barbara Viviani; Valérie Capra; G Enrico Rovati
Journal:  Respir Res       Date:  2006-03-22

5.  Unravelling the role of ADAM 33 in asthma.

Authors:  P A Mahesh
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.